Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Trends in Cancer|July 26, 2017
Watson for Genomics: Moving Personalized Medicine ForwardKahn Rhrissorrakrai, Takahiko Koyama, Laxmi Parida
Bulletin of the World Health Organization|August 4, 2020
Variant analysis of SARS-CoV-2 genomesTakahiko Koyama, Daniel Platt, Laxmi Parida
Pathogens (Basel, Switzerland)|May 3, 2020
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody TreatmentTakahiko Koyama, Dilhan Weeraratne, Jane L Snowdon, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2015
[Results of a Special Drug Use-Results Survey on Compliance to Tegafur/Uracil(UFT)Adjuvant Chemotherapy for Non-Small Cell Lung Cancer]Takahiko Koyama, Yuya Funato, Yasunobu Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Results of a Special Drug Use-Results Survey on Palonosetron Hydrochloride in Patients Aged 18 Years and Younger]Tomohiro Kojima, Takahiko Koyama, Yuji Kunitomi, et al.
Frontiers in Microbiology|August 22, 2022
Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic GamesTakahiko Koyama, Reitaro Tokumasu, Kotoe Katayama, et al.
Future Microbiology|March 30, 2022
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, et al.
Japanese Journal of Clinical Oncology|January 13, 2021
Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancerTakayuki Yoshino, Hiroyuki Uetake, Yuya Funato, et al.
Frontiers in Medicine|February 28, 2022
Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, et al.
Pageof 2